Cargando…

Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

OBJECTIVES: To evaluate the potential of immunosuppressed patients to mount B-cell and T-cell responses to COVID-19 booster vaccination (third vaccination). METHODS: Patients with primary immunodeficiency (PID), immune-mediated inflammatory diseases (IMIDs) on CD20-depleting treatment with rituximab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koehm, Michaela, Klippstein, Maximilian, Dauth, Stephanie, Hallmann, Konstantin, Kohmer, Niko, Burkhardt, Harald, Ciesek, Sandra, Geisslinger, Gerd, Rabenau, Holger F, Behrens, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476126/ https://www.ncbi.nlm.nih.gov/pubmed/37652553 http://dx.doi.org/10.1136/rmdopen-2023-003094

Ejemplares similares

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Kohmer, Niko, et al.
Publicado: (2021)

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
por: Kohmer, Niko, et al.
Publicado: (2023)

Clinical performance of different SARS‐CoV‐2 IgG antibody tests
por: Kohmer, Niko, et al.
Publicado: (2020)

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
por: Kohmer, Niko, et al.
Publicado: (2020)

Increasing but insufficient neutralizing activity against Omicron-BA.1 after a second booster dose of mRNA-1273 vaccine in chronic haemodialysis patients
por: Ovcar, Eugen, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response
por: Lammert, Alexander, et al.
Publicado: (2022)

Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
por: Kohmer, Niko, et al.
Publicado: (2021)

Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
por: Kohmer, Niko, et al.
Publicado: (2022)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
por: Patyna, Sammy, et al.
Publicado: (2022)

Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients
por: Ovcar, Eugen, et al.
Publicado: (2023)

Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis
por: Behrens, Frank, et al.
Publicado: (2016)

Reply to Fabbris et al. A Viable Alternative. Comment on “Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751”
por: Hoehl, Sebastian, et al.
Publicado: (2022)

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro
por: Kohmer, Niko, et al.
Publicado: (2021)

Immunodeficiency and Mucosal Immunity
por: Cunningham-Rundles, Charlotte
Publicado: (2005)

Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis
por: Scharbatke, Eva C., et al.
Publicado: (2016)

Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab
por: Behrens, Frank, et al.
Publicado: (2018)

Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab
por: Schmalzing, Marc, et al.
Publicado: (2020)

Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study
por: Behrens, Frank, et al.
Publicado: (2020)

Use of a “critical difference” statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis
por: Behrens, Frank, et al.
Publicado: (2019)

Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities
por: Koehm, Michaela, et al.
Publicado: (2023)

Aflatoxin-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus Disease
por: Jiang, Yi, et al.
Publicado: (2008)

Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination
por: Yu-ping, Zhao, et al.
Publicado: (2023)

Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
por: Hoffmann, Markus, et al.
Publicado: (2023)

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
por: Catalioto, Rose-Marie, et al.
Publicado: (2021)

How to Naturally Support the Immune System in Inflammation—Essential Oils as Immune Boosters
por: Grazul, Magdalena, et al.
Publicado: (2023)

Covid-19 Vaccines — Immunity, Variants, Boosters
por: Barouch, Dan H.
Publicado: (2022)

Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
por: Fidler, Sarah, et al.
Publicado: (2022)

Effect of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster on Human Immunodeficiency Virus Reservoirs and Immune Markers
por: Rai, M Ali, et al.
Publicado: (2022)

Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology
por: Szepanowski, Fabian, et al.
Publicado: (2021)

Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity
por: Li, Ko-Jen, et al.
Publicado: (2021)

Landscape of B cell immunity and related immune evasion in human cancers
por: Hu, Xihao, et al.
Publicado: (2019)

Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination
por: Sasanami, Misaki, et al.
Publicado: (2023)

Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
por: Enßle, Julius C., et al.
Publicado: (2022)

2709. Immune Response After Diphtheria and Tetanus Toxoid Booster in Patients with Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibody
por: Tovikkai, Dissaruj, et al.
Publicado: (2019)

Unbalanced Immune System: Immunodeficiencies and Autoimmunity
por: Giardino, Giuliana, et al.
Publicado: (2016)

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
por: Glehr, Gunther, et al.
Publicado: (2022)

Role of vitamins and minerals as immunity boosters in COVID-19
por: Kumar, Puneet, et al.
Publicado: (2021)

Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas
por: Huang, Sicong, et al.
Publicado: (2020)

Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma
por: Zhang, Chi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9m1b9ecibq2vdu6aofuo2i9fc1